Skip to NavigationSkip to content

Nigeria

Almost 400 Nigerian medical dispensaries shut down for sub-standard practice

Nigeria has seen almost 400 of its medicine dispensaries shut down over “unethical practices and lack of compliance, it has emerged.

A total of 387 establishments were forcibly closed in the country’s Benue State, corresponding to 44 pharmacies and 343 patent medicine shops. Further to this, an additional 16 businesses – made up of 13 patent and proprietary medicine vendors and three pharmacies – were issued with compliance directives.

Nigerian agency strongly contests that 70% of drugs are fake

Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that 70% of the drugs available on the Nigerian market are fake or counterfeit.

Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that 70% of the drugs available on the Nigerian market are fake or counterfeit.

Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens

Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million of the nation’s citizens currently live with the condition. Health professionals gathered to discuss the situation at a press conference in Lagos to herald the first incarnation of the summit, highlighting the need for immediate action.

Childhood mortality from diarrhoea falls by third

A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade 2005 to 2015. The Lancet report revealed that the major factors involved in the drop were improved access to clean water, reduction of childhood undernutrition and the introduction of a vaccine for rotavirus – a common cause of diarrhoea.

Wellcome Trust makes Ebola research investment

Ebola image

The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment for longer-term medical research in Africa.

This comes a week after the World Health Organization said it will allow untested treatments for Ebola to be used in West Africa, as the death toll from the virus passes the 1,000 mark.

GSK invests £130m in Africa

gsk image

GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years - money which the company says will create at least 500 jobs and improve local training.

Up to £100m will go into beefing up its existing manufacturing facilities in Nigeria and Kenya, plus building as many as five new factories in Africa, with possible locations including Rwanda, Ghana and Ethiopia.

The company will also establish 25 academic chairs at African universities in disciplines such as science, engineering and public health - and train 10,000 community health workers.

Pfizer: WikiLeaks claims "preposterous"

Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official in order to have a clinical trial lawsuit dropped.

The company was sued after a 1996 meningitis trial in which 11 children died during the testing of its new antibiotic Trovan against the standard treatment ceftriaxone.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches